NUTEX Investments Plc Logo

NUTEX Investments Plc

NUTEX | BUD

Overview

Corporate Details

ISIN(s):
HU0000182308 (+1 more)
LEI:
529900UQ0PDQODW4SV81
Country:
Hungary
Address:
Cziráki utca 24-32. A. ép. II. em. 141. ajtó, 1163 Budapest
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NUTEX Investments Plc is an investment holding company operating in the health and wellness sector. Through its subsidiaries, the company focuses on the research, development, manufacturing, and distribution of health-preserving products, dietary supplements, cosmetics, and medicinal preparations. A key area of its activity involves products based on natural active ingredients, particularly utilizing natural humic acid (Humifulvát) extracted from peat. The company provides its portfolio of nutritional, cosmetic, and pharmaceutical products to consumers in Hungary and international markets, aiming to promote physical and mental well-being.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for NUTEX Investments Plc. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NUTEX Investments Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NUTEX Investments Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Moberg Pharma Logo
Pharma company commercializing a novel topical treatment for nail fungus in European markets.
Sweden MOB
Mochida Pharmaceutical Co.,Ltd. Logo Japan 4534
Modalis Therapeutics Corporation Logo Japan 4883
MORISHITA JINTAN CO.,LTD. Logo Japan 4524
MUROMACHI CHEMICALS INC. Logo Japan 4885
Nanexa AB Logo
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
Sweden NANEXA
Nanoform Finland OYJ Logo
Pharma tech firm engineering nanoparticles to enhance drug performance and development.
Finland NANOFH
NANO MRNA Co.,Ltd. Logo Japan 4571
NanoRepro AG Logo
Develops and distributes rapid diagnostic self-tests for early disease detection.
Germany NN6
NATAC Logo
Develops sustainable, science-backed botanical extracts for global health and nutrition markets.
Spain NAT